Mariano García-Valiño

moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA.

GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.

Axenya is an Uruguayan health technology company that offers and manages healthcare plans in a digital, efficient, and transparent fashion. The private company is located in Uruguay and has subsidiaries in Brazil. The company integrates cutting-edge software, hardware, artificial intelligence, intensive data-analysis, and behavioral sciences to improve the efficiency in delivering health services and expand the companies' toolbox. Axenya delivers excellent patient satisfaction, superior clinic results, and lower costs, improving the quality per dollar spent by companies while allowing access to modern medicine to all employees and dependents.

Bausch & Lomb Holdings, Inc. developed, manufactured, and sold eye health products. Its products included contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and was headquartered in Rochester, NY.

Disprofarma SA is an Argentinean pharmaceutical distribution company that has been operating since 1978. The private company boasts strengths in laboratories, commercial network, contact technology, innovation, connectivity, and transparency. The company has a team of collaborators throughout the country and are a leader in pharmaceutical distribution. Disprofarma places a strong emphasis on providing solid attention to their exclusive intranet customers, which include drug stores, institutions, and pharmacies. The company also offers management and consultation services through their exclusive intranet. Additionally, Disprofarma has an exclusive portal for pharmacies and transportation.